Aug 18, 2026 08:35AM
Aug 11, 2026 04:05PM
Aug 10, 2026 04:07PM
Aug 10, 2026 04:05PM
Jul 23, 2026 08:04AM
Jul 23, 2026 08:00AM
Jul 16, 2026 03:22PM Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
Jun 29, 2026 08:00AM
Jun 22, 2026 02:07PM
Jun 16, 2026 04:05PM
Jun 11, 2026 04:17PM
Jun 9, 2026 04:05PM
May 15, 2026 06:25AM
May 13, 2026 04:05PM IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
Apr 14, 2026 08:00AM
Apr 1, 2026 06:07AM
Mar 27, 2026 05:58AM
Mar 26, 2026 04:06PM
Mar 26, 2026 04:05PM
Mar 13, 2026 08:00AM
Mar 13, 2026 08:00AM Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
Mar 3, 2026 08:00AM
Jan 5, 2026 12:27PM
Jan 5, 2026 07:00AM
Nov 11, 2025 04:51AM
Nov 10, 2025 04:05PM
Oct 13, 2025 04:05PM
Oct 13, 2025 04:05PM iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch
Oct 6, 2025 07:15AM
Oct 6, 2025 07:15AM
Sep 24, 2025 07:05AM
Sep 8, 2025 07:16AM
Sep 8, 2025 07:15AM
Sep 8, 2025 07:00AM
Aug 25, 2025 09:15AM IMDX CFO Andrea James Featured in Empowered Patient Podcast on Democratizing Molecular Diagnostics
Aug 12, 2025 06:41AM
Aug 11, 2025 04:05PM
Jul 30, 2025 04:05PM
Jul 28, 2025 04:05PM
Jun 23, 2025 04:06PM
Jun 23, 2025 04:05PM
Jun 17, 2025 07:00AM Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville

329,910 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All